These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
188 related articles for article (PubMed ID: 1851871)
1. Heterotypic passive protection induced by synthetic peptides corresponding to VP7 and VP4 of bovine rotavirus. Ijaz MK; Attah-Poku SK; Redmond MJ; Parker MD; Sabara MI; Frenchick P; Babiuk LA J Virol; 1991 Jun; 65(6):3106-13. PubMed ID: 1851871 [TBL] [Abstract][Full Text] [Related]
2. Priming and induction of anti-rotavirus antibody response by synthetic peptides derived from VP7 and VP4. Ijaz MK; Alkarmi TO; el-Mekki AW; Galadari SH; Dar FK; Babiuk LA Vaccine; 1995 Mar; 13(4):331-8. PubMed ID: 7793126 [TBL] [Abstract][Full Text] [Related]
3. Assembly of recombinant rotavirus proteins into virus-like particles and assessment of vaccine potential. Redmond MJ; Ijaz MK; Parker MD; Sabara MI; Dent D; Gibbons E; Babiuk LA Vaccine; 1993; 11(2):273-81. PubMed ID: 8382422 [TBL] [Abstract][Full Text] [Related]
4. Particle-bombardment-mediated DNA vaccination with rotavirus VP4 or VP7 induces high levels of serum rotavirus IgG but fails to protect mice against challenge. Choi AH; Basu M; Rae MN; McNeal MM; Ward RL Virology; 1998 Oct; 250(1):230-40. PubMed ID: 9770437 [TBL] [Abstract][Full Text] [Related]
5. Homotypic protection against rotavirus-induced diarrhea in infant mice breast-fed by dams immunized with the recombinant VP8* subunit of the VP4 capsid protein. Gil MT; de Souza CO; Asensi M; Buesa J Viral Immunol; 2000; 13(2):187-200. PubMed ID: 10892999 [TBL] [Abstract][Full Text] [Related]
6. Antibody-independent protection against rotavirus infection of mice stimulated by intranasal immunization with chimeric VP4 or VP6 protein. Choi AH; Basu M; McNeal MM; Clements JD; Ward RL J Virol; 1999 Sep; 73(9):7574-81. PubMed ID: 10438847 [TBL] [Abstract][Full Text] [Related]
7. Particle bombardment-mediated DNA vaccination with rotavirus VP6 induces high levels of serum rotavirus IgG but fails to protect mice against challenge. Choi AH; Knowlton DR; McNeal MM; Ward RL Virology; 1997 May; 232(1):129-38. PubMed ID: 9185596 [TBL] [Abstract][Full Text] [Related]
8. Heterotypic protection following oral immunization with live heterologous rotaviruses in a mouse model. Feng N; Vo PT; Chung D; Vo TV; Hoshino Y; Greenberg HB J Infect Dis; 1997 Feb; 175(2):330-41. PubMed ID: 9203654 [TBL] [Abstract][Full Text] [Related]
9. Protective immunity induced by rotavirus DNA vaccines. Chen SC; Fynan EF; Robinson HL; Lu S; Greenberg HB; Santoro JC; Herrmann JE Vaccine; 1997 Jun; 15(8):899-902. PubMed ID: 9234543 [TBL] [Abstract][Full Text] [Related]
11. Sequence analysis of the VP4, VP6, VP7, and NSP4 gene products of the bovine rotavirus WC3. Ciarlet M; Hyser JM; Estes MK Virus Genes; 2002 Mar; 24(2):107-18. PubMed ID: 12018701 [TBL] [Abstract][Full Text] [Related]
12. Antibody response to serotype-specific and cross-reactive neutralization epitopes on VP4 and VP7 after rotavirus infection or vaccination. Taniguchi K; Urasawa T; Kobayashi N; Ahmed MU; Adachi N; Chiba S; Urasawa S J Clin Microbiol; 1991 Mar; 29(3):483-7. PubMed ID: 1709946 [TBL] [Abstract][Full Text] [Related]
13. Characterization of a synthetic peptide mimicking trypsin-cleavage site of rotavirus VP4. Ijaz MK; Alkarmi TO; Sabara MI; Frenchick PJ; el Mekki AA; Naiem M; Nur-e-Kamal MS; Frossard PM; Dar FK; Babiuk LA Comp Immunol Microbiol Infect Dis; 1995 Jun; 18(3):145-60. PubMed ID: 7554816 [TBL] [Abstract][Full Text] [Related]
14. Serum-neutralizing antibody to VP4 and VP7 proteins in infants following vaccination with WC3 bovine rotavirus. Ward RL; Knowlton DR; Greenberg HB; Schiff GM; Bernstein DI J Virol; 1990 Jun; 64(6):2687-91. PubMed ID: 2159538 [TBL] [Abstract][Full Text] [Related]
15. Inhibition of rotavirus infection in vitro and in vivo by a synthetic peptide from VP4. Ijaz MK; Nur-E-Kamal MS; Dar FK; Uduman S; Redmond MJ; Attah-Poku SK; Dent D; Babiuk LA Vaccine; 1998; 16(9-10):916-20. PubMed ID: 9682337 [TBL] [Abstract][Full Text] [Related]
16. Homotypic and heterotypic serum isotype-specific antibody responses to rotavirus nonstructural protein 4 and viral protein (VP) 4, VP6, and VP7 in infants who received selected live oral rotavirus vaccines. Yuan L; Ishida S; Honma S; Patton JT; Hodgins DC; Kapikian AZ; Hoshino Y J Infect Dis; 2004 May; 189(10):1833-45. PubMed ID: 15122520 [TBL] [Abstract][Full Text] [Related]
17. Immunization with baculovirus-expressed recombinant rotavirus proteins VP1, VP4, VP6, and VP7 induces CD8+ T lymphocytes that mediate clearance of chronic rotavirus infection in SCID mice. Dharakul T; Labbe M; Cohen J; Bellamy AR; Street JE; Mackow ER; Fiore L; Rott L; Greenberg HB J Virol; 1991 Nov; 65(11):5928-32. PubMed ID: 1656079 [TBL] [Abstract][Full Text] [Related]
18. Subunit Vaccine Preparation of Bovine Rotavirus and Its Efficacy in Mice. Suocheng W; Tuanjie C; Changjun S; Fengling T; Zhongren M Iran J Immunol; 2015 Sep; 12(3):188-97. PubMed ID: 26412637 [TBL] [Abstract][Full Text] [Related]
19. Immune responses and protection obtained by oral immunization with rotavirus VP4 and VP7 DNA vaccines encapsulated in microparticles. Herrmann JE; Chen SC; Jones DH; Tinsley-Bown A; Fynan EF; Greenberg HB; Farrar GH Virology; 1999 Jun; 259(1):148-53. PubMed ID: 10364499 [TBL] [Abstract][Full Text] [Related]